CM
AMPE

Caption Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Caption Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-108
Closed -$55K – 1915
2021
Q2 		$55K Buy
+108
New +$58K ﹤0.01% 1230

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

Caption Management's AMPE Position: Q3 2021 in Review

Caption Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2021, closing a stake of 108 shares — an estimated $55K sold.

Caption Management first reported a position in AMPE in Q2 2021 and held it in 1 quarter. The position peaked at $55K in Q2 2021. 121 funds tracked by Wall St. Rank hold AMPE as of Q3 2021.

  • Caption Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2021 after selling out during the quarter.
  • Caption Management sold 108 Ampio Pharmaceuticals Inc. shares in Q3 2021, an estimated $55K.
  • Caption Management first reported a position in Ampio Pharmaceuticals Inc. in Q2 2021 and held it in 1 quarter.
  • Caption Management's Ampio Pharmaceuticals Inc. position peaked at $55K in Q2 2021.
  • 121 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2021.

Based on Caption Management's 13F filing for Q3 2021, filed 12 Nov 2021.